Last reviewed · How we verify
NCT04873258: MASLD
Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
trial testing Bioimpedence Vector Analysis in Healthy in 2,000 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Richmond Research Institute |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 27 September 2019 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Bioimpedence Vector Analysis
Conditions studied
- Healthy — all drugs for Healthy →
- Fatty Liver — all drugs for Fatty Liver →
- MASLD — all drugs for MASLD →
- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease — all drugs for MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease →
Sponsor
Richmond Research Institute
Who can join
Adults 18 to 80, any sex, with Healthy or Fatty Liver. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A generic screening study to establish structural and/or functional baselines of specific organs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04873258
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Richmond Research Institute trials
Trials by the same sponsor.
- NCT06809686 — Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care · recruiting
- NCT01984827 — Effect of Glucose on QTc Interval in Type 1 Diabetes · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04873258 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Richmond Research Institute
- Last refreshed: 23 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04873258.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing